首页> 外文期刊>Cytology and genetics >Expression of Bel-2 in Imprint Smears of Endometrial Carcinoma
【24h】

Expression of Bel-2 in Imprint Smears of Endometrial Carcinoma

机译:Bel-2在子宫内膜癌的印记涂片中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

The aims of this study were to determine the expression of Bcl-2 in endometrial adenocarcinomas in imprint smears as an alternative technique rather than the frozen section and to correlate the results with clinicopathologic parameters of primary untreated endometrial cancer patients. One hundred twenty-six patients with endometrial carcinoma were evaluated with samples freshly resected after a total abdominal hysterectomy during a 29-month period. One hundred two cases were type I and 24 type II endometrial adenocarcinomas. Positive expression of Bcl-2 was observed only in type I and in low grade carcinomas. Immunocytochemical findings from Bcl-2 stain, appeared to be a valuable predictor of endometrial cancer diagnosis and postoperative prognosis in most cases in endometrial cytology with imprint smears. Furthermore, positive expression of Bcl-2 was related to morphologic features of less aggressiveness (pathogenetic type I, low-grade, early advanced stage, deep myometrial involvement 1/2 or not) tumors.
机译:该研究的目的是确定印记涂片子宫内膜腺癌中Bcl-2的表达,作为替代技术而不是冷冻部分,并将结果与​​初级未经处理的子宫内膜癌患者的临床病理参数相关联。在29个月期间,在总腹腔切除术后新切除的样品评价一百二十六患者。一百个两种病例是I和24型II型子宫内膜腺癌。仅在I型和低级癌中观察到Bcl-2的阳性表达。来自BCL-2染色的免疫细胞化学发现,在内膜细胞学中的内膜细胞学中的大多数情况下,对子宫内膜癌诊断和术后预后的有价值预测性。此外,Bcl-2的阳性表达与侵略性较小的形态学特征有关(致病型I,低级,早期晚期,深度闭经累及<1/2或不)肿瘤的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号